ArticleJournal of neuro-oncology2021

Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.

Andrés F Cardona et al.PubMed ↗Publisher ↗

No numbers read from the abstract.